New study to track RSV Shot's Real-World power in hospitalized infants
NCT ID NCT07485907
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will look back at medical records of 1,000 babies under 1 year old who were hospitalized with bronchiolitis. Researchers want to see if a new medicine called nirsevimab helped prevent severe RSV infections. The goal is to understand how well the shot works in real life during the 2025/2026 season.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRONCHIOLITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
ACTIV
Créteil, 94000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple decision tool cut time on breathing support for sick infants?
- Could a lower oxygen threshold get kids home sooner?
- Laughing gas may soothe painful tube insertion in toddlers
- Which flow rate helps babies breathe better? new study tests two options
- AI stethoscope aims to cut unnecessary antibiotics in kids with cough
- Ultrasound vs x-ray: a new way to spot lung issues in sick babies?